The Latest Breaking News from Dermatology

After finding success investing in the more obviously lucrative corners of American medicine — like surgery centers and dermatology practices — private equity firms have moved aggressively into the industry’s more hidden niches: They are pouring billions into the business of clinical drug trials.

THE ARTICLES ON THESE PAGES ARE PRODUCED BY BUSINESS REPORTER, WHICH TAKES SOLE RESPONSIBILITY FOR THE CONTENTS

A recent acquisition could pair nicely with the commercial infrastructure being built for the recently-approved Opzelura.

The COVID-19 vaccines can help keep you from getting the nasty virus, missing many days of work or school, and ending up in the hospital or the graveyard.

The U.S. Food and Drug Administration (FDA) has approved Spectrum Pharmaceuticals’ (NASDAQ:SPPI) lead asset ROLVEDON (eflapegrastim-xnst) injection to decrease the incidence of infection, as manifested by febrile neutropenia. Spectrum Pharmaceuticals shares traded as high as 3.17 percent, in a range of $1.21 to $1.30 on day volume of 6.8 million…

By John Vandermosten, CFA NASDAQ:NOVN READ THE FULL NOVN RESEARCH REPORT

Melanoma is a type of skin cancer that develops in cells that produce your skin's pigment. Regular skin checks can help you identify the warning signs and differentiate melanoma from noncancerous skin formations, according to the American Academy of Dermatology.

Our body naturally produces collagen — it's also a 2 billion dollar supplement industry. Inverse spoke to experts from the fields of orthopedics, nutrition, sports, and dermatology to separate collagen fact from fiction.

 

By John Vandermosten, CFA NASDAQ:NOVN READ THE FULL NOVN RESEARCH REPORT